English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/203274
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:


Genetic mutational status of genes regulating epigenetics: Role of the histone methyltransferase KMT2D in triple negative breast tumors

AuthorsMorcillo-Garcia, Sara; Noblejas-López, María del Mar; Nieto-Jiménez, Cristina; Pérez-Peña, Javier; Nuncia-Cantarero, Miriam; Győrffy, Balázs; Amir, Eitan; Pandiella, Atanasio ; Galán-Moya, Eva María; Ocaña, Alberto
Issue Date16-Apr-2019
PublisherPublic Library of Science
CitationPLoS ONE 14(4): e0209134 (2019)
Abstract[Purpose]: Epigenetic regulating proteins like histone methyltransferases produce variations in several functions, some of them associated with the generation of oncogenic processes. Mutations of genes involved in these functions have been recently associated with cancer, and strategies to modulate their activity are currently in clinical development.
[Methods]: By using data extracted from the METABRIC study, we searched for mutated genes linked with detrimental outcome in invasive breast carcinoma (n = 772). Then, we used downstream signatures for each mutated gene to associate that signature with clinical prognosis using the online tool “Genotype-2-Outcome” (http://www.g-2-o.com). Next, we performed functional annotation analyses to classify genes by functions, and focused on those associated with the epigenetic machinery.
[Results]: We identified KMT2D, SETD1A and SETD2, included in the lysine methyltransferase activity function, as linked with poor prognosis in invasive breast cancer. KMT2D which codes for a histone methyltransferase that acts as a transcriptional regulator was mutated in 6% of triple negative breast tumors and found to be linked to poor survival. Genes regulated by KMT2D included RAC3, KRT23, or KRT14, among others, which are involved in cell communication and signal transduction. Finally, low expression of KMT2D at the transcriptomic level, which mirror what happens when KMT2D is mutated and functionally inactive, confirmed its prognostic value.
[Conclusion]: In the present work, we describe epigenetic modulating genes which are found to be mutated in breast cancer. We identify the histone methyltransferase KMT2D, which is mutated in 6% of triple negative tumors and linked with poor survival.
Description© 2019 Morcillo-Garcia et al.
Publisher version (URL)http://dx.doi.org/10.1371/journal.pone.0209134
Appears in Collections:(IBMCC) Artículos
Files in This Item:
File Description SizeFormat 
Genetic_Morcillo_Garcia_Art2019.pdf2,41 MBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.